Year 2025 / Volume 117 / Number 5
Editorial
Low risk, high cost: challenging the role of gastric cancer screening in low-prevalence countries

237-240

DOI: 10.17235/reed.2025.11087/2024

Hugo Uchima, Leticia Moreira-Ruiz, Glòria Fernández Esparrach,

Abstract
Gastric cancer is the second commonest gastrointestinal (GI) neoplasm, with a high mortality rate and highly variable regional incidence data associated with factors such as diet, genetics, and infection with Helicobacter pylori. In high-risk countries as Japan and South Korea endoscopic screening has shown its potential to reduce this cancer’s mortality. However, in low-risk countries such as Spain, where population screening is not cost-effective, a selective approach is advised focused on high-risk groups, including patients with a family history of gastric cancer, or in the form of opportunistic screening during gastroscopy for other clinical indications. High-quality gastroscopy is key for the identification of early lesions. This includes using high-definition endoscopes with chromoendoscopy, pursuing optimal mucosal visibility with washes or premedication, systematically inspecting all of the mucosa, investing adequate observation times, and using risk stratification tools such as EGGIM or OLGIM. Endoscopic surveillance is particularly advisable for high-risk precursor lesions, with intervals adjusted for patient profile. Further research is crucial for optimizing these interventions and reducing the condition’s mortality rate.
New comment
Comments
No comments for this article
References
[1] Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clinicians 2024; 74: 229–263. doi:10.3322/caac.21834
[2] Zhang X, Li M, Chen S, et al. Endoscopic Screening in Asian Countries Is Associated With Reduced Gastric Cancer Mortality: A Meta-analysis and Systematic Review. Gastroenterology 2018; 155: 347-354.e9. doi:10.1053/j.gastro.2018.04.026
[3] Cubiella J, Pérez Aisa Á, Cuatrecasas M, et al. Documento de posicionamiento de la AEG, la SEED y la SEAP sobre cribado de cáncer gástrico en poblaciones con baja incidencia. Gastroenterología y Hepatología 2021; 44: 67–86. doi:10.1016/j.gastrohep.2020.08.004
[4] Rodríguez-de-Santiago E, Frazzoni L, Fuccio L, et al. Digestive findings that do not require endoscopic surveillance – Reducing the burden of care: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2020; 52: 491–497. doi:10.1055/a-1137-4721
[5] Ligato I, Dottori L, Sbarigia C, et al. Systematic review and meta‐analysis: Risk of gastric cancer in patients with first‐degree relatives with gastric cancer. Aliment Pharmacol Ther 2024; 59: 606–615. doi:10.1111/apt.17872
[6] Stjepanovic N, Moreira L, Carneiro F, et al. Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Annals of Oncology 2019; 30: 1558–1571. doi:10.1093/annonc/mdz233
[7] Dinis-Ribeiro M, Shah S, El-Serag H, et al. The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines. Gut 2024; 73: 1607–1617. doi:10.1136/gutjnl-2024-333029
[8] Llach J, Salces I, Guerra A, et al. Endoscopic surveillance for familial intestinal gastric cancer in low‐incidence areas: An effective strategy. Intl Journal of Cancer 2024; 154: 124–132. doi:10.1002/ijc.34714
[9] Pabla BS, Shah SC, Corral JE, et al. Increased Incidence and Mortality of Gastric Cancer in Immigrant Populations from High to Low Regions of Incidence: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology 2020; 18: 347-359.e5. doi:10.1016/j.cgh.2019.05.032
[10] Sun D, Mülder DT, Li Y, et al. The Effect of Nationwide Organized Cancer Screening Programs on Gastric Cancer Mortality: A Synthetic Control Study. Gastroenterology 2024; 166: 503–514. doi:10.1053/j.gastro.2023.11.286
[11] Pimentel-Nunes P, Libânio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy 2019; 51: 365–388. doi:10.1055/a-0859-1883
[12] Fernández-Esparrach G, Marín-Gabriel JC, Díez Redondo P, et al. Documento de posicionamiento de la AEG, la SEED y la SEAP sobre calidad de la endoscopia digestiva alta para la detección y vigilancia de las lesiones precursoras de cáncer gástrico. Gastroenterología y Hepatología 2021; 44: 448–464. doi:10.1016/j.gastrohep.2021.01.002
[13] Pimentel-Nunes P, Libânio D, Lage J, et al. A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions. Endoscopy 2016; 48: 723–730. doi:10.1055/s-0042-108435
[14] Rodríguez-Carrasco M, Esposito G, Libânio D, et al. Image-enhanced endoscopy for gastric preneoplastic conditions and neoplastic lesions: a systematic review and meta-analysis. Endoscopy 2020; 52: 1048–1065. doi:10.1055/a-1205-0570
[15] Dohi O, Yagi N, Naito Y, et al. Blue laser imaging-bright improves the real-time detection rate of early gastric cancer: a randomized controlled study. Gastrointestinal Endoscopy 2019; 89: 47–57. doi:10.1016/j.gie.2018.08.049
[16] Romańczyk M, Ostrowski B, Lesińska M, et al. The prospective validation of a scoring system to assess mucosal cleanliness during EGD. Gastrointestinal Endoscopy 2024; 100: 27–35. doi:10.1016/j.gie.2024.01.012
[17] Burke E, Harkins P, Moriarty F, et al. Does Premedication with Mucolytic Agents Improve Mucosal Visualization during Oesophagogastroduodenoscopy: A Systematic Review and Meta-Analysis. Surgery Research and Practice 2021; 2021: 1–12. doi:10.1155/2021/1570121
[18] Fuentes-Valenzuela E, Pérez-Arenas E, De Benito Sanz M, et al. Prospective cohort study evaluating premedication with simethicone and n-acetilcysteine for upper diagnostic gastrointestinal endoscopy. Rev Esp Enferm Dig 2022; doi:10.17235/reed.2022.8576/2022
[19] Córdova H, Barreiro-Alonso E, Castillo-Regalado E, et al. Applicability of the Barcelona scale to assess the quality of cleanliness of mucosa at esophagogastroduodenoscopy. Gastroenterología y Hepatología 2024; 47: 246–252. doi:10.1016/j.gastrohep.2023.05.011
[20] Esposito G, Dilaghi E, Costa-Santos C, et al. The Gastroscopy RAte of Cleanliness Evaluation (GRACE) Scale: an international reliability and validation study. Endoscopy 2024; a-2422-0856. doi:10.1055/a-2422-0856
[21] Bisschops R, Areia M, Coron E, et al. Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy 2016; 48: 843–864. doi:10.1055/s-0042-113128
[22] Yao K. The endoscopic diagnosis of early gastric cancer. Ann Gastroenterol 2013; 26: 11–22
[23] Kim TJ, Pyo JH, Byun YH, et al. Interval Advanced Gastric Cancer After Negative Endoscopy. Clinical Gastroenterology and Hepatology 2023; 21: 1205-1213.e2. doi:10.1016/j.cgh.2022.08.027
[24] Kawamura M, Uedo N, Koike T, et al. Kyoto classification risk scoring system and endoscopic grading of gastric intestinal metaplasia for gastric cancer: Multicenter observation study in Japan. Digestive Endoscopy 2022; 34: 508–516. doi:10.1111/den.14114
[25] Rei A, Ortigão R, Pais M, et al. Metachronous lesions after gastric endoscopic submucosal dissection: first assessment of the FAMISH prediction score. Endoscopy 2023; 55: 909–917. doi:10.1055/a-2089-6849
Related articles

Letter

A rare case of hepatoid gastric adenocarcinoma

DOI: 10.17235/reed.2024.10285/2024

Digestive Diseases Image

Ink stained gastric lesions: a rare cause of gastrointestinal bleeding

DOI: 10.17235/reed.2021.8141/2021

Editorial

Screening guide for hepatitis C virus infection in Spain

DOI: 10.17235/reed.2020.7728/2020

Review

New non-invasive biomarkers for colorectal cancer screening

DOI: 10.17235/reed.2020.7233/2020

Special Article

Strategy for the Elimination of Hepatitis C in Cantabria

DOI: 10.17235/reed.2020.7108/2020

Digestive Diseases Image

Cervical arthrodesis penetrated into the esophagus detected by gastroscopy

DOI: 10.17235/reed.2019.6222/2019

Special Article

Quality indicators in gastroscopy. Gastroscopy procedure

DOI: 10.17235/reed.2019.6023/2018

Letter

Primary squamous cell carcinoma of the stomach: a rare entity

DOI: 10.17235/reed.2018.5900/2018

Editorial

Colorectal cancer screening and survival

DOI: 10.17235/reed.2018.5870/2018

Letter

Why anal cytology is not enough in a dysplasia screening program

DOI: 10.17235/reed.2018.5678/2018

Letter to the Editor

Alopecia areata as a paraneoplastic syndrome of gastric cancer

DOI: 10.17235/reed.2016.4455/2016

Citation tools
Uchima H, Moreira-Ruiz L, Fernández Esparrach G. Low risk, high cost: challenging the role of gastric cancer screening in low-prevalence countries. 11087/2024


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 5 visits.
This article has been downloaded 0 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 19/01/2025

Accepted: 20/01/2025

Online First: 27/03/2025

Published: 08/05/2025

Article Online First time: 67 days

Article editing time: 109 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2025 y Creative Commons. The Spanish Journal of Gastroenterology